IRON III HYDROXIDE DEXTRAN

This brand name is authorized in Nigeria.

Active ingredients

The drug IRON III HYDROXIDE DEXTRAN contains one active pharmaceutical ingredient (API):

1	Iron III hydroxide dextran complex UNII 95HR524N2M - IRON DEXTRAN
	Read more about Iron dextran

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-0407	Solution for injection	Iron Dextran Injection INJ_SOL 250 mg/mL 5 mL x 10's (in ampoules)	Intravenous injection/infusion IRON DEXTRAN INJECTION IRON DETRAN INJECTION BP 250MG/5ML A4-0407 Drugs Imported Product 5MLX10AMPOULES 14-06-2023 MALVEN MEDICS INTERNATIONAL COMPANY LTD, WILMER STREET, ILUPEJU ILUPEJU LAGOS 08037205003 malvenmedics@yahoo.com PHARMAX INDIA PVT. LTD., 9, Kurla Industrial Estate, Off Lal Bahadur Shashtri Marg, Ghatkopar (West), Mumbai – 400086, India.	27/03/2025
C4-1221	Solution for injection	Iron Dextran Injection INJ_SOL 250 mg/5 mL 1 x 5 mL ampoule	Solution for Injection	10/11/2020

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
B03AC	Iron trivalent, parenteral preparations	B Blood and blood forming organs → B03 Antianemic preparations → B03A Iron preparations
Discover more medicines within B03AC

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-0407, C4-1221